Givaudan SA
GIVN: XSWX (CHE)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|D? | LOCK|<& | LOCK|@q#SP% |
Givaudan Earnings: Sales Growth Normalizes While Long-Term Targets Remain Intact; Shares Undervalued
Givaudan reported like-for-like sales growth of 5.1% for full-year 2025, with growth slowing sequentially in the fourth quarter. Weaker sales led to a 30-basis-point reduction in the full-year comparable EBITDA margin. Shares declined 6% at the opening of the market on Jan. 29.
